ARS Pharmaceuticals, Inc. (SPRY)
NASDAQ: SPRY · Real-Time Price · USD
3.510
-0.080 (-2.23%)
Nov 17, 2026, 9:30 AM EST - Market open
ARS Pharmaceuticals Market Cap
ARS Pharmaceuticals has a market cap or net worth of $352.85 million as of November 17, 2026. It is the 16,513th most valuable company in the world and the 2,962nd biggest in the United States. Its market cap has decreased by 56.52% in one year.
Market Cap
352.85M
Enterprise Value
411.52M
1-Year Change
-56.52%
Global Rank
Country Rank
#2,962 United States
Category
ChartMarket Cap Chart
Since November 9, 2022, ARS Pharmaceuticals's market cap has decreased from $568.25M to $352.85M, a decrease of -37.90%. That is a compound annual growth rate of -11.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 352.85M | -69.36% |
| Dec 31, 2025 | 1.15B | 12.32% |
| Dec 31, 2024 | 1.03B | 94.90% |
| Dec 29, 2023 | 526.06M | -34.23% |
| Dec 30, 2022 | 799.86M | 40.76% |
| Nov 9, 2022 | 568.25M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SL Science Holding | 414.58M |
| Tectonic Therapeutic | 413.27M |
| Fennec Pharmaceuticals | 410.25M |
| MapLight Therapeutics | 402.92M |
| Puma Biotechnology | 401.70M |
| Contineum Therapeutics | 387.16M |
| Opus Genetics | 384.68M |
| Rezolute | 383.42M |